Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT

被引:0
|
作者
Reece, Donna E.
Rodriguez, Giovanni Piza [1 ]
Belch, Andrew [2 ]
Szwajcer, David [3 ,4 ]
Kovacs, Michael J. [5 ]
Shustik, Chaim [6 ]
Bahlis, Nizar J. [7 ]
White, Darrell J. [8 ]
Pantoja, Mariela [1 ]
Chen, Christine
Kukreti, Vishal
Anglin, Peter [9 ]
Trudel, Suzanne [10 ]
机构
[1] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada
[2] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[3] CancerCare Manitoba, Dept Hematol, Winnipeg, MB, Canada
[4] Univ Manitoba, Winnipeg, MB, Canada
[5] Victoria Hosp, London Hlth Sci Ctr, London, ON N6A 4G5, Canada
[6] McGill Univ, Div Haematol, Ctr Hlth, Montreal, PQ, Canada
[7] Univ Calgary, Div Hematol, Calgary, AB, Canada
[8] Queen Elizabeth 2 Hlth Sci Ctr, Div Hematol, Halifax, NS, Canada
[9] Southlake Reg Canc Ctr, Newmarket, ON, Canada
[10] Princess Margaret Hosp, McLaughlin Ctr Mol Med, Toronto, ON M4X 1K9, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:822 / 822
页数:1
相关论文
共 50 条
  • [1] Bortezomib-Based Therapy without Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma Patients with t(4;14): A Canadian National Trial
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Szwajcer, David
    Minuk, Leonard A.
    Pantoja, Mariela
    Belch, Andrew
    Shustik, Chaim
    Stakiw, Julie
    White, Darrell J.
    Chen, Christine
    Kukreti, Vishal
    Tiedemann, Rodger E.
    Sebag, Michael
    Jenkins, Gayle
    Bahlis, Nizar J.
    Le, Lisa W.
    Trudel, Suzanne
    BLOOD, 2011, 118 (21) : 1704 - 1704
  • [2] Bortezomib-Based Therapy, without Stem Cell Transplantation, for Newly Diagnosed Multiple Myeloma Patients with t(4;14)
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Belch, Andrew
    Szwajcer, David
    Pantoja, Mariela
    Kovacs, Michael
    Shustik, Chaim
    Bahlis, Nizar J.
    White, Darrell J.
    Chen, Christine
    Kukreti, Vishal
    Anglin, Peter
    Stewart, A. Keith
    Trudel, Suzanne
    BLOOD, 2009, 114 (22) : 1485 - 1486
  • [3] Bortezomib-Based Triplet Therapy As First Line Treatment in Newly Diagnosed Multiple Myeloma Patients in Peru
    Vasquez, Jule F.
    Cordova, Naty Lopez
    Castillo, Claudia
    Saavedra, Alexandra
    Calle, Cindy
    Chavez, Lourdes Isabel Lopez
    Alcarraz, Cindy Elizabeth
    Rios, Pedro Eduardo Lovato
    Matuk, Alexandra La Torre
    Laboriano, Jorge
    Vilcarano, Abner
    Tokumura, Carmen
    Quintana, Shirley
    Samanez-Figari, Cesar
    Vidaurre, Tatiana
    BLOOD, 2024, 144 : 6997 - 6998
  • [4] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
    Zhou, Xin
    Wang, Jing
    Xia, Jun
    Cheng, Feng
    Mao, Jingjue
    Zhu, Jianwei
    Guo, Hongfeng
    CANCER BIOMARKERS, 2018, 22 (01) : 43 - 48
  • [5] Treatment of newly diagnosed myeloma: Bortezomib-based triplet
    Rajan, Archana M.
    Rajkumar, S. Vincent
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 700 - 702
  • [6] An Economic Evaluation of Bortezomib-Based Induction Therapy in Double Transplant Protocols for Newly Diagnosed Multiple Myeloma Patients
    Wang, Si-Tien
    Duh, Mei Sheng
    Huang, Hui
    White, Leigh Ann
    Chang, Eva
    Esseltine, Dixie-Lee
    Marantz, Jing L.
    BLOOD, 2008, 112 (11) : 831 - 832
  • [7] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    HAEMATOLOGICA, 2014, 99 (11)
  • [8] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
    Zhou, Xin
    Wang, Jing
    Xia, Jun
    Cheng, Feng
    Mao, Jingjue
    Zhu, Jianwei
    Guo, Hongfeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S5 - S5
  • [9] Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
    Wei, Min
    Guo, Honggang
    Liu, Siwei
    Xu, Fangfang
    Zhang, Yin
    Shi, Jie
    Xu, Zhiwei
    Chen, Yuqing
    MEDICINE, 2021, 100 (41) : E27521
  • [10] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    BLOOD, 2012, 120 (21)